• Offers 100% Coverage with 90% Bioavailabilty
• Lowers the risk of resistance & assured patient compliance as com[are to ofloxacin as well as Ciprofloxacin
• Active against gram +ve cocci including pencillin resistance pneumococci & anaerobes.
• MIC is double against S.Pneumoniae [Int.j.of Antimicrobial Agent (1999) 43]